Huang Defa, Shen Haibin, Xie Fangfang, Hu Die, Jin Qing, Hu Yuexin, Zhong Tianyu
Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Precision Medicine Center, First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
J Biol Eng. 2024 Jun 6;18(1):36. doi: 10.1186/s13036-024-00431-6.
Exosomes are nanovesicles with multiple components used in several applications. Mesenchymal stem cells (MSCs) are well known for their great potential in clinical applications. MSC-derived exosomes (MSC-Exos) have been shown to mediate tissue regeneration in various diseases, including neurological, autoimmune, and inflammatory diseases, cancer, ischemic heart disease, lung injury, and liver fibrosis. They can modulate the immune response by interacting with immune effector cells in the presence of anti-inflammatory compounds and are involved in intercellular communication through various types of cargo. This review summarizes the MSC-Exos-mediated tissue regeneration in various diseases, including neurological, cardiovascular, liver, kidney, articular cartilage, and oral tissue applications. In addition, we discuss the challenges and prospects of MSC-Exos in tissue regeneration.
外泌体是具有多种成分的纳米囊泡,应用于多种领域。间充质干细胞(MSCs)因其在临床应用中的巨大潜力而广为人知。已证明源自间充质干细胞的外泌体(MSC-Exos)可介导多种疾病的组织再生,包括神经疾病、自身免疫性疾病、炎症性疾病、癌症、缺血性心脏病、肺损伤和肝纤维化。它们可在存在抗炎化合物的情况下通过与免疫效应细胞相互作用来调节免疫反应,并通过各种类型的货物参与细胞间通讯。本综述总结了MSC-Exos介导的各种疾病中的组织再生,包括神经、心血管、肝脏、肾脏、关节软骨和口腔组织应用。此外,我们还讨论了MSC-Exos在组织再生中的挑战和前景。
Front Immunol. 2021
Curr Stem Cell Res Ther. 2020
Bioengineering (Basel). 2025-8-5
J Ovarian Res. 2025-7-24
Biomolecules. 2024-10-24
Cell Commun Signal. 2024-1-2
Interdiscip Med. 2023-10
Cost Eff Resour Alloc. 2023-11-30
Mol Ther Nucleic Acids. 2022-4-27
Cardiovasc Toxicol. 2022-6